Article
Exon7 Targeted CRISPR-Prime Editing Approaches for <i>SMN2</i> Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression
2022-03-21
Abstract excerpt
Spinal Muscular Atrophy (SMA) is a fatal neuromuscular disease characterized by motor neuron loss and advanced muscle weakness, which occurs in functional SMN (Survival Motor Neuron) protein deficiency with SMN1 gene-induced deletions and mutations. The incidence of SMA, which is an autosomal recessive disease, is 1/10,000 in the world. The SMN protein acts as a molecular chaperone in the formation of the spliceo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 02d26186-912d-53f3-a146-c9da6b93d879
- DOI
- 10.1101/2022.03.21.484406
